Brief: Trinity Biotech Announces Strategic Investment In Novus Diagnostics To Advance Rapid Sepsis Testing Platform
25/10/2024 14:32
Oct 25 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES STRATEGIC INVESTMENT IN NOVUS
DIAGNOSTICS TO ADVANCE RAPID SEPSIS TESTING PLATFORM
* TRINITY BIOTECH PLC - ACQUIRES 12.5% EQUITY STAKE IN NOVUS
FOR
$2.5 MILLION
Source text for Eikon: ID:nGNX9zKXtJ
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM